circulating tumor DNA
Artemis DNA to Provide Datar Cancer Genetics Liquid Biopsy Tests in the US, Vietnam Under $250M Deal
Under the five-year exclusive agreement, Artemis DNA will offer Datar Cancer Genetics' Trucheck Pragma and Cancertrack tests in the US and Vietnam.
Delfi Diagnostics Begins Second, Larger Prospective Lung Cancer Screening Trial
The trial will pair a liquid biopsy screen with conventional low-dose CT scan screening for 15,000 patients at high risk for lung cancer.
Proof-of-Principle Study Points to Possibility of Monitoring Pediatric ALL With Plasma Samples
Capture-based blood plasma sequencing helped track disease persistence or relapse and identify microbes that may cause infection in the immunosuppressed patients.
At the AACR annual meeting, both companies shared new data on their technologies' performance in detecting early and late-stage cancers.
Tyra Biosciences, xCures Launch Real-World Biomarker Study in FGFR-Mutated Bladder Cancer
The firms are analyzing ctDNA in patients' blood and urine samples after treatment with Janssen's Balversa to study FGFR inhibitor resistance and further treatment options.